Cheng Yi Pharma(SH:603811) Sou Hu Cai Jing·2025-09-07 20:15Trading Information Summary - On September 5, 2025, Chengyi Pharmaceutical (603811) closed at 14.43 yuan, up 1.26%, with a turnover rate of 3.92%, a trading volume of 128,500 shares, and a transaction amount of 182 million yuan [1]. - On the same day, the net outflow of main funds was 5.15 million yuan, accounting for 2.83% of the total transaction amount; the net outflow of retail funds was 14.23 million yuan, accounting for 7.81%; while retail investors had a net inflow of 19.38 million yuan, accounting for 10.64% of the total transaction amount [1][3]. Company Announcement Summary - Chengyi Pharmaceutical will hold its second extraordinary general meeting of shareholders on September 15, 2025, to review amendments to several governance systems [1]. - The meeting will take place at 9:30 AM at the company's R&D building in Dongtou District, Wenzhou, and online voting will be conducted through the Shanghai Stock Exchange system [1]. - A total of 12 sub-proposals will be submitted for review, including revisions to the "Implementation Rules for Cumulative Voting at Shareholders' Meetings," "Independent Director Work Rules," and various management and decision-making systems [1]. - The revisions are based on the latest regulations from the Company Law, Securities Law, and guidelines for listed companies, with key changes including the unification of the term "shareholders' meeting" to "shareholders' assembly" and the transfer of supervisory responsibilities to the audit committee [1].